20890 ⎘
Medicinal preparations containing peptides Peptides of undefined number of amino acids; Derivatives thereof
Use of exosomes to promote or enhance hair growth
#302ENTERAL FORMULATIONS FOR PRETERM INFANTS COMPRISING OPTIMISED PHENYLALANINE INTAKE LEVELS
#303LOW FREQUENCY GLATIRAMER ACETATE THERAPY
#304Methods and compositions for wound treatment
#305Stabilized compounds having secondary structure motifs
#306TUBE FEED FORMULATIONS AND METHODS FOR USING SAME
#307Methods for maintaining pegylation of polypeptides
#308Stable formulations for parenteral injection of peptide drugs
#309Compositions and uses of antimicrobial materials with tissue-compatible properties
#310COMBINATION FORMULATION OF LAQUINIMOD AND GLATIRAMER ACETATE WITH AMINO ACIDS
#311Compositions and Methods for the Prevention and Treatment of Metabolic Diseases
#312Treatment of autoimmune disorders and infections using antagonists of SGK1 activity
#313Pharmaceutical composition and method for reducing scar formation
#314METHODS AND COMPOSITIONS FOR THE TREATMENT OF BETA-THALASSEMIA
#315NLRP6 Inflammasome Intestinal Epithelium Mucus Secretion
#316RNA AND PROTEIN NETWORKS THAT LOCALLY CONTROL BRAIN WIRING DURING DEVELOPMENT
#317Balancing an Unbalanced Sympathetic Nervous System
#318Compositions and Methods for Yeast Extracellular Vesicles as Delivery Systems
#319Lipids and compositions for intracellular delivery of biologically active compounds
#320Implantable meshes for controlling the movement of fluids
#321SELECT SINGLE NUCLEOTIDE POLYMORPHISMS PREDICTIVE OF RESPONSE TO GLATIRAMER ACETATE
#322ANIMAL FEED COMPOSITIONS INCLUDING SPENT FILTER MEDIA CONTAINING DIATOMACEOUS EARTH
#323MODULATION OF EPIGENETIC STRESS RESPONSE
#324Pharmaceutical compositions having antibacterial, antiviral, and other immunostimulatory activities
#325Targeted contrast agents and methods for targeting contrast agents
#326Process for manufacturing glatiramer acetate product
#327USE OF NUCLEIC ACIDS WITH REDUCED PRESSURE THERAPY
#328METHOD FOR FOODBORNE PATHOGEN REDUCTION IN POULTRY
#329Diagnostic markers for multiple sclerosis
#330Method for the prevention and treatment of acne
#331Methods and compositions for modifying mucous membranes
#332Protease assisted native-protein delivery approach (PANDA)
#333NANOROD MATERIALS AND METHODS OF MAKING AND USING SAME
#334Diagnosis of respiratory tract infectious disease using urine specimens
#335Prophylactic use for prevention of infections
#336pH SENSITIVE CARRIER AND PREPARATION METHOD THEREOF, AND pH SENSITIVE DRUG AND pH SENSITIVE DRUG COMPOSITION EACH CONTAINING THE CARRIER, AND METHOD FOR TREATING OR PREVENTING DISEASES USING THE SAME
#337Methods and Compositions for Preserving the Viability of Photoreceptor Cells
#338Targeting microRNAs for the treatment of fibrosis
#339Methods and compositions for wound treatment
#340Therapeutic uses of enzyme inhibitors
#341Tube feed formulations and methods for using same
#342Cell penetrating peptides for intracellular delivery of molecules
#343Metabolic imprinting effects of specifically designed lipid component
#344CORRECTORS ACTING THROUGH MSD1 OF CFTR PROTEIN
#345Analysis of amino acid copolymer compositions
#346Palatable nutritional composition comprising a nucleotide and/or a nucleoside and a taste masking agent
#347PERFORIN 2 DEFENSE AGAINST INVASIVE AND MULTIDRUG RESISTANT PATHOGENS
#348DRUG CARRIER HAVING SELF-ASSEMBLED 3-D NUCLEIC ACID NANOSTRUCTURE
#349SYSTEMS AND METHODS FOR CHARACTERIZATION OF MULTIPLE SCLEROSIS
#350PROCESS FOR THE MEASUREMENT OF THE POTENCY OF GLATIRAMER ACETATE
#351RITUXIMAB INDUCTION THERAPY FOLLOWED BY GLATIRAMER ACETATE THERAPY
#352COMPOSITION AND USE
#353Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
#354Combined Treatment Utilizing VB-201
#355Modified Fc molecules
#356Siglec-9 binding agents
#357Analysis of amino acid copolymer compositions
#358Compositions and methods to inactivate and/or reduce production of microbial toxins
#359Fermented cationic peptide-based antimicrobial extract compatible with anionic compounds
#360TREATMENT OF DISORDERS WITH ALTERED VASCULAR BARRIER FUNCTION
#361Methods and compositions for the disruption of biofilms
#362Composition with high antimicrobial activity and low toxicity
#363METHODS OF MODULATING DLK STABILITY
#364Low protein infant formula with increased essential amino acids
#365METHODS FOR TREATING INFLAMMATION
#366ORAL TRANSMUCOSAL DELIVERY OF GLATIRAMER ACETATE
#367Neuronal pain pathway
#368Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria
#369Administration of cells and cellular extracts for rejuvenation
#370Crosslinked peptide hydrogels
#371Triazine cationic polymers and methods of use thereof
#372POLYMERIC NANOCARRIERS WITH DUAL IMAGES TRACKING PROBE AND METHOD FOR MANUFACTURING THE SAME
#373Methods and Pharmaceutical Compositions for Treatment of Gastrointestinal Stromal Tumors
#374Rapid formation of chitosan sponges using guanosine 5′-diphosphate: injectable scaffolds for tissue regeneration and drug delivery
#375Microfabricated nanopore device for sustained release of therapeutic agent
#376Microfabricated nanopore device for sustained release of therapeutic agent
#377Multicomponent degradable cationic polymers
#378Low frequency glatiramer acetate therapy
#379HETEROZYGOUS MOUSE WITH AN INACTIVATED BRD1 ALLELE AND USES IN PSYCHIATRY
#380Programmable drug delivery profiles of tumor-targeted bacteria
#381Treatment of noise induced hearing loss
#382METHOD AND PHARMACEUTICAL COMPOSITION COMPRISING ADIPOSE STEM CELL EXTRACT FOR TREATING OR PREVENTING NEUROLOGIC DISEASE
#383PERFORIN 2 DEFENSE AGAINST INVASIVE AND MULTIDRUG RESISTANT PATHOGENS
#384Aminoalcohol lipidoids and uses thereof
#385ANTICANCER TREATMENT
#386Low frequency glatiramer acetate therapy
#387ALGAL-BASED ANIMAL FEED COMPOSITION, ANIMAL FEED SUPPLEMENT, AND USES THEREOF
#388Compositions and Methods for Regulating Cytochrome c-Mediated Apoptosis by tRNA
#389Procoagulant compounds
#390Microfabricated nanopore device for sustained release of therapeutic agent
#391Methods and Compositions for Modulating Beta Cell Proliferation
#392AGENTS FOR TREATING CYSTIC FIBROSIS
#393INSULIN INDEPENDENCE AMONG PATIENTS WITH DIABETES UTILIZING A PPI IN COMBINATION WITH AN IMMUNE TOLERANCE AGENT
#394Chondrocyte proliferation promoting agent
#395Nutritional product
#396COMPOSITION AND METHOD FOR AFFECTING CYTOKINES AND NF-KB
#397Whey Protein Composition with a Reduced Astringency
#398Modulation of TLR4-signaling pathway
#399NUTRITIONAL PRODUCTS AND METHODS OF IMPROVING EXERCISE PERFORMANCE AND REDUCING EXERCISE INDUCED IMPAIRMENT OF IMMUNE FUNCTION
#400Dietary Compositions and Methods for Protection Against Chemotherapy, Radiotherapy, Oxidative Stress, and Aging
#401Methods for modulating Th1/Th2 cell balance by increasing leptin activity
#402Palladium catalyzed reactions executed on solid-phase peptide synthesis supports for the production of self-assembling peptides embedded with complex organic electronic subunits
#403Antigen delivery vectors and constructs
#404Genetic markers predictive of response to glatiramer acetate
#405Targeting micrornas for the treatment of fibrosis
#406Nutritive fragments, proteins and methods
#407Compositions and uses of antimicrobial materials with tissue-compatible properties
#408Use of secretor, lewis and sialyl antigen levels in clinical samples as predictors of risk for disease
#409Implantable meshes for controlling the movement of fluids
#410Lipids and compositions for intracellular delivery of biologically active compounds
#411Compositions and Methods for Diagnosing, Preventing and Treating Intracranial Aneurysms
#412METHODS TO IDENTIFY COMPOUNDS USEFUL FOR THE TREATMENT OF PROLIFERATIVE AND DIFFERENTIATIVE DISORDERS
#413Preparation for use of aspartate and vitamin B12 or biotin for regulating ketone bodies
#414Combination of a leucine source and an omega-3 unsaturated fatty acid source for use in the treatment of hypercalcaemia
#415Compositions and Methods for Reducing CTL Exhaustion
#416Nutritional composition for improving the mammalian immune system
#417Method of producing 4-1BB binding molecules and associated nucleic acids
#418Method for identifying bromodomain inhibitors
#419Pharmaceutical composition for a foaming eye drop
#420METHOD FOR REDUCING BLOOD PRESSURE USING INHIBITORS OF PLASMA KALLIKREIN
#421Predictive biomarker of survival in the treatment of renal cell carcinoma
#422Antibiotic composition comprising a chemotactic agent and a nutrient dispersion
#423Functionalized nanoparticles for intracellular delivery of biologically active molecules
#424Sustained releasing pharmaceutical composition
#425PAR-1 Antagonists for Use in the Treatment or Prevention of Influenza Virus Type A Infections
#426Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza hemagglutinin
#427BIODEGRADABLE BONE FILLERS, MEMBRANES AND SCAFFOLDS CONTAINING COMPOSITE PARTICLES
#428METHODS FOR ENHANCING MUSCLE PROTEIN SYNTHESIS FOLLOWING CONCURRENT TRAINING
#429Prussian blue-inspired constructs for multimodal imaging and therapy
#430WNT PATHWAY INHIBITORS FOR TREATING VIRAL INFECTIONS
#431INSULIN INDEPENDENCE AMONG PATIENTS WITH DIABETES UTILIZING A PPI IN COMBINATION WITH AN IMMUNE TOLERANCE AGENT
#432Methods for generating cardiomyocytes
#433MODULATORS OF 4-1BB AND IMMUNE RESPONSES
#434Use of plant cell membrane treatment of obesity
#435Use of plant cell membrane treatment of obesity
#436Compositions of a peptide targeting system for treating cancer
#437Methods for treatment of cancer by targeting Sirt5
#438TREATMENT OF OBESITY
#439Nutritional compositions containing magnesium threonate and uses thereof
#440Metabolic imprinting effects of specifically designed lipid component
#441METHOD FOR TREATMENT OF DEGENERATIVE BRAIN DISORDERS COMPRISING INHIBITOR OF SUM01 AND BACE1 INTERACTION AS AN ACTIVE INGREDIENT
#442Body Weight Gain Suppresing Composition and Food Product Comprising the Same
#443Emulsion containing a non-live medicinal substance
#444Palatable nutritional composition comprising a nucleotide and/or a nucleoside and a taste masking agent
#445Lipids and compositions for intracellular delivery of biologically active compounds
#446Lipids and compositions for intracellular delivery of biologically active compounds
#447Stabilized compounds having secondary structure motifs
#448Preparation for use of aspartate for regulating glucose levels in blood
#449Injectable Non-Aqueous Suspension
#450Hydrogels with covalently linked polypeptides
#451Use of secretor, Lewis and sialyl antigen levels in clinical samples as predictors of risk for disease
#452THERAPEUTIC PEPTIDE-POLYMER CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS
#453TREATMENT OF AUTOIMMUNE DISORDERS AND INFECTIONS USING ANTAGONISTS OF SGK1 ACTIVITY
#454Galactose-pronged carbohydrate compounds for the treatment of diabetic nephropathy and associated disorders
#455Methods of evaluating peptide mixtures
#456Pharmaceutical composition and methods for peptide treatment
#457Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation
#458JAK/STAT INHIBITORS AND MAPK/ERK INHIBITORS FOR RSV INFECTION
#459DELIVERY OF COMPOUNDS WITH REHYDRATED BLOOD CELLS
#460Nanoparticles containing pH-responsive peptide
#461B-type plexin antagonists and uses thereof
#462Composition comprising expression or activity inhibitors of Ninjurin1 for the prevention and treatment of inflammatory disease
#463GLP-1 receptor stabilizers and modulators
#464Methods of administering D-dopachrome tautomerase (D-DT) to treat ischemia-reperfusion injury
#465Neuroprotective and neurorestorative methods and compositions
#466KETOGENIC DIET COMPOSITION FOR THE TREATMENT OF CHEMO THERAPY AND/OR RADIATION THERAPY PATIENTS
#467Methods of evaluating diethylamide in peptide mixtures for the preparation of glatiramer acetate
#468TREATMENT OF DISORDERS WITH ALTERED VASCULAR BARRIER FUNCTION
#469GRAPHITE-COATED MAGNETIC NANOPARTICLES
#470Use of cytokine-releasing, biodegradable particles in hyaluronic acid for the treatment of cartilage defects, in particular of osteoarthrosis
#471Enhancement of the action of anti-infective agents and of central and peripheral nervous system agents and transportation of nucleic acid substances
#472Methods of delivering stable topical drug compositions
#473Methods of delivering stable topical drug compositions
#474Synergistic Combinations of Polyene Fungicides and Non-Ribosomal Peptides and Related Methods of Use
#475Combinations of therapeutic agents for treating melanoma
#476TOPICAL DRUG DELIVERY USING PHOSPHATIDYLCHOLINE
#477MODULATION OF PILR RECEPTORS TO TREAT SEPSIS
#478COMPOSITIONS AND METHODS FOR TREATING GASTROINTESTINAL MOTILITY DYSFUNCTION
#479Transducible polypeptides for modifying metabolism
#480Siglec-9 Binding Agents
#481SHEAR CONTROLLED RELEASE FOR STENOTIC LESIONS AND THROMBOLYTIC THERAPIES
#482Neuroprotection in Demyelinating Diseases
#48315-PGDH in colon cancer
#484COMPOSITIONS, THE PREPARATION AND USE THEREOF
#485Pharmaceutical composition for preventing or treating Th17-mediated disease comprising poly-gamma-glutamic acid
#486Compositions and uses of materials with high antimicrobial activity and low toxicity
#487Crosslinked peptide hydrogels
#488COMPOSITIONS OF CELLS, MEDIA, AND METHODS THEREOF
#489COMBINATORIAL METHODS AND COMPOSITIONS FOR TREATMENT OF MELANOMA
#490COMBINATION TREATMENT OF MAJOR DEPRESSIVE DISORDER
#491Methods for generating cardiomyocytes
#492Biopolymer produced by fermenting the extract of soybean with folic acid and a composition containing thereof
#493Proteolytically resistant hydrogen bond surrogate helices
#494Treatment of Avian Species with Inhibitors of P110 Delta Signaling
#495Methods of Engraftment
#496Tube feed packages and methods for using same
#497Tube feed formulations and methods for using same
#498METHOD OF ENHANCING MUSCLE PROTEIN SYNTHESIS
#499Promoting Erythropoietin, Erythrocyte, and Hematopoietic Stem Cell Production By Activating HIF In OsteoBlasts
#500Compositions with hematopoietic and immune activity
#501Method of inhibiting cell proliferation induced by alternatively spliced tissue factor by administering a monoclonal antibody
#502IL-27 Antagonists for Treating Inflammatory Diseases
#503Targeting microRNAs for the treatment of fibrosis
#504NLRC5 AS A TARGET TO INTERVENE MHC CLASS 1-MEDIATED IMMUNE RESPONSES
#505VH4 CODON SIGNATURE FOR MULTIPLE SCLEROSIS
#506CALPAIN-3 INHIBITORS FOR TREATING MUSCULAR DYSTROPHIES AND CARDIOMYOPATHIES
#507Low frequency glatiramer acetate therapy
#508TREATMENT OF NEURODEGENERATIVE DISEASE WITH CREB-BINDING PROTEIN
#509Methods for the treatment and the diagnosis of cancer
#510Antagonists of Sema3E/PlexinD1 interaction as anti-cancer agents
#511Compositions for inhibiting gene expression and uses thereof
#512Retractor
#513REGULATORY FACTOR OF FOXP3 AND REGULATORY T CELLS AND USE THEREOF
#514COMPOSITIONS AND METHODS FOR REMOVAL OR DESTRUCTION OF AMYLOID FIBRIL OR AMYLOID ADHESIN COMPRISING AGGREGATES
#515Method for growing, restoring and regenerating hair
#516Methods of using small compounds to enhance myeloid derived suppressor cell function for treating autoimmune diseases
#517Vaccine for enveloped viruses
#518TREATMENT OF PULMONARY EDEMA
#519NOVEL COMPOUNDS AND THEIR EFFECTS ON FEEDING BEHAVIOUR
#520Methods and compositions for reducing interleukin-4 or interleukin-13 signaling
#521Low protein infant formula with increased essential amino acids
#522REVERSED BIARYL SPIROAMINOOXAZOLINE ANALOGUES AS ALPHA2C ADRENERGIC RECEPTOR MODULATORS
#523COMPOUNDS TARGETING THE VEGF AND/OR HIF PATHWAY SUCH AS SORAFENIB OR VATALANIB FOR USE IN THE TREATMENT OF OTITIS MEDIA
#524Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria
#525TREATMENT OF PROLIFERATIVE DISORDERS
#526TREATMENT OF MULTIPLE SCLEROSIS
#527TREATMENT OF MULTIPLE SCLEROSIS WITH COMBINATION OF LAQUINIMOD AND GLATIRAMER ACETATE
#528Compositions and methods for the prevention and treatment of metabolic diseases
#529TOPICAL TRANSDERMAL METHOD FOR DELIVERING NUTRIENTS THROUGH THE SKIN FOR EXPEDITED WOUND HEALING
#530LIQUID NUCLEOTIDES/NUCLEOSIDES-CONTAINING PRODUCT
#531Combined Treatment Utilizing VB-201
#532Surfactant composition
#533Antigen delivery vectors and constructs
#534PROCESS FOR THE MEASUREMENT OF THE POTENCY OF GLATIRAMER ACETATE
#535Mucosal delivery compositions comprising a peptide complexed with a crown compound and/or a counter ion
#536Synergistic combinations of polyene fungicides and non-ribosomal peptides and related methods of use
#537Enhancement of the action of anti-infective agents and of central and peripheral nervous system agents and transportation of nucleic acid substances
#538Neuronal pain pathway
#539NOVEL ANTIMICROBIAL AGENTS
#540Lipids and compositions for intracellular delivery of biologically active compounds
#541BODY WEIGHT GAIN SUPPRESSING COMPOSITION AND FOOD PRODUCT COMPRISING THE SAME
#542Method for inducing cancer cell apoptosis or inhibiting the cancer cell migration
#543Compositions and Methods for Regulating Cytochrome c-Mediated Apoptosis by tRNA
#5444-1BB binding molecules
#545Reduced volume formulation of glatiramer acetate and methods of administration
#546Stable formulations for parenteral injection of peptide drugs
#547Transducible polypeptides for modifying metabolism
#548Novel Microorganism Bacillus megaterium Toha Producing L-Type Poly-Gamma-Glutamic Acid and L-Type Poly-Gamma-Glutamic Acid Produced Thereby
#549PAR-1 antagonists for use in the treatment or prevention of influenza virus type A infections
#550Compositions of a peptide targeting system for treating cancer
#551COMPOSITIONS RELATING TO A PHOSPHOPROTEIN AND METHODS OF USE
#552ANIMAL FEEDS AND VETERINARY COMPOSITIONS
#553Systems and methods of removing and managing heavy metals
#554POLYMER PARTICLES AND USES THEREOF
#555Peptide based peroxidase inhibitors and methods of using same
#556IL-27 Antagonists for Treating Inflammatory Diseases
#557Methods To Identify Compounds Useful For The Treatment Of Proliferative And Differentiative Disorders
#558Depot systems comprising glatiramer or pharmacologically acceptable salt thereof
#559Methods and compositions for wound treatment
#560Lysine compounds and their use in site- and chemoselective modification of peptides and proteins
#561INDUCTION OF NEUROGENESIS AND STEM CELL THERAPY IN COMBINATION WITH COPOLYMER 1
#562METHODS OF TREATING AUTISM AND AUTISM SPECTRUM DISORDERS
#563Biological nasal bridge implant and method of manufacture
#564Multicomponent degradable cationic polymers
#565Aldehyde-fixed, dried platelets with covalently attached exogenous active agent and method of making thereof
#566COMBINATION OF A LEUCINE SOURCE AND AN OMEGA- 3 UNSATURATED FATTY ACID SOURCE FOR USE IN THE TREATMENT OF HYPERCALCAEMIA
#567Cytokine biomarkers as predictive biomarkers of clinical response for Glatiramer acetate
#568MODULATION OF PILR RECEPTORS TO TREAT SEPSIS
#569External use composition for skin
#570Recombinant hemagglutinin protein of influenza virus and vaccine containing the same
#571Methods And Compositions Related To Synergistic Responses To Oncogenic Mutations
#572Low frequency glatiramer acetate therapy
#573ALKYLSACCHARIDE COMPOSITIONS WITH NUTRACEUTICALS
#574Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin
#575THERAPEUTIC PEPTIDE-POLYMER CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS
#576Antigen delivery vectors and constructs
#577Neuroprotective and neurorestorative method and compositions
#578COMBINATION THERAPY WITH GLATIRAMER ACETATE AND RASAGILINE FOR THE TREATMENT OF MULTIPLE SCLEROSIS
#579Administration of cells and cellular extracts for rejuvenation
#580Depot systems comprising glatiramer or a pharmacologically acceptable salt thereof
#581Modified Fc molecules
#582METHOD FOR REDUCING BLOOD PRESSURE USING INHIBITORS OF PLASMA KALLIKREIN
#583GLP-1 receptor stabilizers and modulators
#584Aminoalcohol lipidoids and uses thereof
#585Biopolymer produced by fermenting the extract of soybean with folic acid and a composition containing thereof
#586Preparation for use of aspartate and vitamin B12 or biotin for regulating ketone bodies
#587Copolymers for suppression of autoimmune diseases, and methods of use
#588Methods for protease assisted protein delivery
#589Compositions and methods for treating insulin resistance and non-insulin dependent diabetes mellitus (type II diabetes)
#590CCR3 inhibition for ocular angiogenesis and macular degeneration
#591Capture agents and related compositions, methods and systems
#592Methods for decreasing leptin levels or activity for treating inflammation
#593Radiolabeled annexins
#594USE OF CYSTEINE-RICH WHEY DERIVED PROTEIN IN PATIENTS RECEIVING CHEMOTHERAPY AND/OR RADIOTHERAPY TO IMPROVE PATIENT SURVIVAL
#595Composition comprising expression or activity inhibitors of ninjurin1 for the prevention and treatment of inflammatory disease
#596Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis
#597Acid-degradable and bioerodible modified polyhydroxylated materials
#598Microfabricated nanopore device for sustained release of therapeutic agent
#599BLOCKADE OF TL1A-DR3 INTERACTIONS TO AMELIORATE T CELL MEDIATED DISEASE PATHOLOGY
#600Drug or dermatological composition containing an avocado peptide extract for treating and preventing pruritus